Skip to Content

HIVID 0.375 (Hivid 0.375 MG)

Generic Name: zalcitabine

Pill with imprint HIVID 0.375 is Pink, Elliptical / Oval and has been identified as Hivid 0.375 MG. It is supplied by Roche Laboratories.

Hivid is used in the treatment of hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Hivid 0.375 MG is not a controlled substance under the Controlled Substances Act (CSA).

Images for HIVID 0.375

Hivid

Generic Name:
zalcitabine
Imprint:
HIVID 0.375
Strength:
0.375 MG
Color:
Pink
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Roche Laboratories
National Drug Code (NDC):
00004-0220

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide